Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aduhelm
Aduhelm
'This is not a shotgun approach to dementia': Hospital execs share how they're rolling out Aduhelm
Beckers Hospital Review
Fri, 06/18/21 - 10:09 am
Biogen
Aduhelm
hospitals
Alzheimer's disease
First patient receives controversial Biogen Alzheimer's drug
NASDAQ
Wed, 06/16/21 - 11:40 pm
Biogen
Aduhelm
Alzheimer's disease
Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval
Seeking Alpha
Wed, 06/16/21 - 11:58 am
Biogen
FDA
Public Citizen
Aduhelm
Alzheimer's disease
Janet Woodcock
Despite controversy, Biogen's Aduhelm is already generating enthusiasm among doctors: survey
Fierce Pharma
Tue, 06/15/21 - 11:43 am
Biogen
Aduhelm
physicians
Alzheimer's disease
These 3 Words From the FDA Ensure the Biogen Drama Is Far From Over
Motley Fool
Tue, 06/15/21 - 10:39 am
FDA
Biogen
Aduhelm
accelerated approvals
Alzheimer's disease
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
Stat
Mon, 06/14/21 - 10:13 am
physicians
Biogen
Aduhelm
FDA
Alzheimer's disease
80% of pharma workers think Aduhelm's approval was a mistake, survey says
Beckers Hospital Review
Thu, 06/10/21 - 11:50 pm
Biogen
Aduhelm
FDA
Alzheimer's disease
Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision
Stat
Thu, 06/10/21 - 11:48 pm
FDA
Alzheimer's disease
Biogen
Aduhelm
Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision
Endpoints
Thu, 06/10/21 - 11:44 pm
Senate
Biogen
Alzheimer's disease
Aduhelm
Janet Woodcock
FDA
AdComm exodus: 2nd expert quits over FDA approval of Biogen's Aduhelm
Fierce Biotech
Thu, 06/10/21 - 11:07 am
FDA
Biogen
Alzheimer's disease
Aduhelm
Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage
Fierce Biotech
Thu, 06/10/21 - 11:04 am
Acumen
IPOs
Aduhelm
Biogen
Faced with historic launch, Biogen to ship Alzheimer's drug in 2 weeks as nearly 1K treatment sites stand ready to go
Fierce Pharma
Wed, 06/9/21 - 11:12 am
Biogen
drug launches
Aduhelm
Alzheimer's disease
Biogen Alzheimer's approval could open the door for other similar drugs
BioPharma Dive
Wed, 06/9/21 - 11:11 am
Biogen
Alzheimer's disease
drug development
aducanumab
Aduhelm
Confirming benefit of Biogen Alzheimer’s disease drug will take 8 years
MedCity News
Wed, 06/9/21 - 11:01 am
Biogen
FDA
clinical trials
Aduhelm
Alzheimer's disease
Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval
Stat
Tue, 06/8/21 - 09:56 pm
Biogen
Aduhelm
Alzheimer's disease
FDA
Biogen Sinks Despite Raft of Analyst Upgrades
Motley Fool
Tue, 06/8/21 - 09:43 pm
Biogen
Aduhelm
aducanumab
Alzheimer's disease
Ready, set, prescribe? Doctors detail why they'll deploy Biogen's new Alzheimer's drug—or not
Fierce Pharma
Tue, 06/8/21 - 12:31 pm
Biogen
Aduhelm
aducanumab
physicians
Alzheimer's disease
Aducanumab approval: ‘We anticipate demand will be high’, says Alzheimer’s Association
Biopharma Reporter
Tue, 06/8/21 - 12:30 pm
Biogen
aducanumab
Alzheimer's disease
Aduhelm
Biogen's 'shockingly broad' Aduhelm label—and $56K price—set up a $10B launch, analysts say
Fierce Pharma
Mon, 06/7/21 - 08:49 pm
Biogen
aducanumab
Aduhelm
FDA
drug pricing
Alzheimer's disease
An extra twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug
Stat
Mon, 06/7/21 - 08:47 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Aduhelm
Pages
« first
‹ previous
1
2
3
4
5
6
7
8